Aldosterone antagonists in addition to renin angiotensin system antagonists for preventing the progression of chronic kidney disease

BACKGROUND: Treatment with angiotensin‐converting enzyme inhibitors (ACEi) and angiotensin receptor blockers (ARB) is used to reduce proteinuria and retard the progression of chronic kidney disease (CKD). However, resolution of proteinuria may be incomplete with these therapies and the addition of a...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Cochrane Database Syst Rev
Hlavní autoři: Chung, Edmund YM, Ruospo, Marinella, Natale, Patrizia, Bolignano, Davide, Navaneethan, Sankar D, Palmer, Suetonia C, Strippoli, Giovanni FM
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley & Sons, Ltd 2020
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8094274/
https://ncbi.nlm.nih.gov/pubmed/33107592
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD007004.pub4
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky